Download FREE Report Sample
Download Free sampleEtomidate is a hypnotic intravenous anesthetic, which is a derivative of imidazoles. It is safe and one of the commonly used drugs for anesthesia induction. Etomidate has been used in clinical practice for 30 years.Etomidate is a non-barbiturate intravenous tranquilizer, which is the hydroxylated salt of imidazole. Its structural formula is as shown in the following figure. Its molecular formula is C14H16N2O2, and its molecular weight is 244.29.Etomidate is insoluble in water and unstable in a neutral solution.
Etomidate Market contains market size and forecasts of Etomidate in global, including the following market information:
Global Etomidate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Etomidate Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Etomidate companies in 2021 (%)
The global Etomidate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Agent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Etomidate include Teva, Johnson & Johnson, Esteve Pharma, Krka, AbbVie, Abbott, Mylan, Luitpold and Par Sterile Products, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Etomidate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Etomidate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Etomidate Market Segment Percentages, by Type, 2021 (%)
Agent
Fat Emulsion
Global Etomidate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Etomidate Market Segment Percentages, by Application, 2021 (%)
Anesthesia
Systemic Traumatic Pain
Other
Global Etomidate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Etomidate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Etomidate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Etomidate revenues share in global market, 2021 (%)
Key companies Etomidate sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Etomidate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Johnson & Johnson
Esteve Pharma
Krka
AbbVie
Abbott
Mylan
Luitpold
Par Sterile Products
Zydus
Emcure
Chengdu Suncadia
Zhejiang Jiuxu
Merck
Braun
Jiangsu Hengrui Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
